Jeffrey A. Frelinger serves as Chairman of the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill. Dr. Frelinger serves as a Member of Scientific Advisory Board at PhaseBio Pharmaceuticals, Inc. and Karo Bio USA, Inc. Dr. Frelinger is a Professor at the University of North Carolina at Chapel Hill. Dr. Frelinger has received numerous awards including a MERIT award from the NIH and a Faculty Research Award from the American Cancer Society. He is a consultant. Dr. Frelinger received his Doctoral degree from the California Institute of Technology (Cal Tech) and carried out Post Doctoral and sabbatical research at University of Michigan Medical School and University of Oxford, UK, respectively.